Surgery for Aortic Stenosis in Children: A 40-Year Experience

Size: px
Start display at page:

Download "Surgery for Aortic Stenosis in Children: A 40-Year Experience"

Transcription

1 CARDIOVASCULAR Surgery for Aortic Stenosis in Children: A 40-Year Experience John W. Brown, MD, Mark Ruzmetov, MD, PhD, Palaniswamy Vijay, PhD, Mark D. Rodefeld, MD, and Mark W. Turrentine, MD Section of Cardiothoracic Surgery, James W. Riley Hospital for Children and Indiana University School of Medicine, Indianapolis, Indiana Background. Aortic stenosis (AS) is encountered in approximately 5% of children with heart disease. The indications for surgery and the surgical techniques for AS are well established. This report focuses on the early and long-term outcomes in children with AS over a 40-year period. Methods. Included in this study were 508 patients ranging in ages from 1 day to 19 years, who were operated on for AS between 1960 and Eighty-one percent (414 of 508) of the patients had left ventricular outflow tract obstruction (LVOTO) at a single level: 40 supravalvar, 242 valvar (critical AS in 85 neonates and young infants and in 157 older children), and 132 subvalvar. Nineteen percent (94 of 508) of the patients had LVOTO at more than one level. Associated congenital cardiac defects were found in 32% of the patients. Results. The overall hospital mortality rate was 8% (40/508) with neonates with critical AS having the highest mortality (33%). The late mortality was 4% for the entire group. Follow-up was 95% complete. The mean follow-up was years. In the subgroup with multilevel LVOTO (n 94), the average intraoperative peak systolic left ventricular-aortic gradient decreased from 80 to 22 mm Hg after repair but increased progressively to mm Hg (p < 0.05) before reintervention was required. One hundred twenty-one patients (24%) underwent 151 reoperations for recurrent or residual LVOTO or aortic regurgitation. Actuarial curves predict a 20-year survival of 88% and 62% freedom from reoperation for all patients with AS. Symptomatic improvement in survivors was excellent (90% New York Heart Association class I). Conclusions. Surgical relief of LVOTO in infants and children can be accomplished with low mortality and morbidity. Neonates with critical AS have significantly higher mortality and morbidity due to their complex anatomy and their critical presentation that affects outcome. Aortic valvotomy delays valve replacement in a significant percentage of children. The Ross procedure and mechanical aortic valve replacements have had a low mortality and morbidity in our series. Valve replacement will eventually be required in most children presenting with valvar AS and multilevel LVOTO while repair of discrete subaortic stenosis and supravalvar AS may not require reoperation in most patients. Children with LVOTO should have lifetime follow-up. (Ann Thorac Surg 2003;76: ) 2003 by The Society of Thoracic Surgeons Congenital aortic stenosis (AS) is a relatively common cardiac anomaly encountered in approximately 5% of all children with heart disease [1, 2]. The left ventricular outflow tract obstruction (LVOTO) may occur at one or more of three separate levels: valvar, subvalvar, or supravalvar. Valvar aortic stenosis (VAS) is the most common cause of LVOTO, and open aortic valvotomy had been the preferred initial operative treatment at our institution until 2000 when balloon valvotomy was introduced and applied in most patients. Aortic stenosis occurring in the neonate or young infant is commonly referred to as neonatal critical AS. The condition accounts for less than 10% of congenital AS cases [1]. The prognosis in neonates without intervention is almost uniformly fatal. The valve Presented at the Poster Session of the Thirty-ninth Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 31 Feb 2, Address reprint requests to Dr Brown, Section of Cardiothoracic Surgery, Indiana University School of Medicine, 545 Barnhill Dr, EH 215, Indianapolis, IN ; jobrown@iupui.edu. is usually dysplastic and has abnormalities in the number and thickness of the cusps, in commissure development, and in cross-sectional area. The valvar abnormality is commonly accompanied by other left-sided cardiac abnormalities including abnormalities of the mitral valve and ventricular cavity, the subaortic region, the aortic arch, and the aortic isthmus. Balloon aortic valvulotomy or open surgical valvotomy are currently advocated by most centers as the procedures of choice for neonatal critical AS [3, 4]. Closed transventricular valvotomy (CTV) was the standard approach in the management of the critical neonatal AS for most neonates at our institution from 1978 to Since 2000 balloon valvotomy has largely replaced surgery for neonates and young children. Subvalvar aortic stenosis (SAS) represents a spectrum of disease ranging from a discrete fibrous membrane to diffuse fibromuscular or tunnel LVOTO. Localized supravalvar aortic stenosis (SVAS) is best repaired by patch aortoplasty as described in 1961 by McGoon [5] and Starr [6] and their associates and was the 2003 by The Society of Thoracic Surgeons /03/$30.00 Published by Elsevier Inc doi: /s (03)

2 Ann Thorac Surg BROWN ET AL 2003;76: SURGERY FOR CONGENITAL AORTIC STENOSIS Abbreviations and Acronyms AAC apical aortic conduit AI aortic insufficiency AS aortic stenosis AVR aortic valve replacement CTV closed transventricular valvotomy ECMO extracorporeal membrane oxygenation LV left ventricular LVOTO left ventricular outflow tract obstruction NYHA New York Heart Association SAS subvalvar aortic stenosis SVAS supravalvar aortic stenosis VAS valvar aortic stenosis Table 2. Level of Left Ventricular Outflow Tract Obstruction in 508 Patients a Level Patients (n) Valvar (N 310) Neonates and young infants with critical 93 VAS ( 6m) Older infants and children with VAS 217 ( 6m) Supravalvar b (N 109) Localized 79 Diffuse 30 Subaortic (N 193) Discrete 144 Diffuse CARDIOVASCULAR technique used by our group. Recent reports have advocated two or three sinus repairs [7, 8]. We agree that multi-sinus repair is helpful in selected cases [9]. Our results with SVAS have been reported previously [9]. The indications for operation and surgical techniques to treat the various types of AS are relatively well established. Although excellent clinical results are often achieved initially, surgical therapy in most cases in which the aortic valve is involved is considered palliative. Most children presenting with VAS will eventually present for valve replacement. The purpose of this study was to retrospectively review the 40-year surgical experience with congenital AS and to evaluate early and late survival rates, morbidity, complications, and the success of various repair techniques. Material and Methods Between 1960 and 2002, 508 patients (330 boys [65%] and 178 girls [35%]) underwent operation for congenital AS at the James Whitcomb Riley Hospital for Children in Indianapolis. Patients ages at operation ranged from 1 day to 19 years (mean SD years). Ninetythree infants (18%) were younger than 6 months of age. Preoperatively most patients (68%) were in New York Heart Association (NYHA) functional class III or IV with symptoms of heart failure. The ages of the patients and the level of obstruction are summarized in Table 1. Eighty-one percent (414 of 508) of the patients had LVOTO at a single level: 40 supravalvar, 242 valvar, and 132 subvalvar. Nineteen percent (94 of 508) of the patients Table 1. Age and Level of Obstruction in 508 Patients With Congenital Aortic Stenosis Level Patients (n) Age (years) Mean SD Range Valvar day to 19 years Supravalvar months to 17 years Subvalvar months to 19 years Multiple day to 19 years Total day to 19 years a Obstruction from one to three levels. b Two patients had supravalvar pulmonary patches placed for supravalvar pulmonary stenosis. VAS valvar aortic stenosis. presented with LVOTO at more than one level. Table 2 summarizes the anatomical types of obstruction in patients with single and multiple levels of LVOTO. Figure 1 depicts the distribution of patients in our series and their preoperative, intraoperative, and late follow-up gradients before any reoperative interventions. All patients underwent preoperative cardiac echocardiography or catheterization, or both. Peak aortic gradients ranged from 0 to 200 mm Hg (mean mm Hg; Table 3). Patients with low aortic gradients ( 35 mm Hg) underwent operation because of cardiac symptoms (dyspnea, angina, syncope, and fatigue) or had associated aortic regurgitation. At initial presentation, aortic valve regurgitation was present in 66 patients (13%) and was mild in 41, moderate in 17, and severe in 8 patients. Patients with severe aortic incompetence underwent initial valve replacement. Operative Techniques Initial surgical procedure performed in 508 children with congenital AS is given in Table 4. Most patients who underwent operation for congenital AS had a median sternotomy. The exceptions were 22 patients receiving an apical aortic conduit (AAC) and 23 neonates who underwent CTV through a left lateral thoracotomy. Both procedures were accomplished without the aid of cardiopulmonary bypass. Cardiopulmonary bypass was used for most of the other operations except for patients undergoing CTV through sternotomy. Patients on bypass were systemically cooled to 28 C with a membrane oxygenator. The approach to valvar, subvalvar, or supravalvar stenosis was through an oblique incision made in the ascending aorta and extending inferiorly into the noncoronary sinus of Valsalva. The aortic valve was bicuspid in 371 patients (73%), tricuspid in 107 (21%), and unicuspid in 30 (6%). After aortic closure, the left ventricular (LV)-aortic gradient was assessed by invasive measurements and by transesophageal echocardiography (since 1985) to confirm the degree of successful relief of the pressure gradient across the LVOT and any degree of aortic regurgitation produced.

3 CARDIOVASCULAR Fig 1. Distribution and disposition of patients with congenital aortic stenosis who underwent various surgical repairs. (AAC apical aortic conduit; AH aortic homograft; AVR aortic valve replacement; HT heart transplant; pt patient.) 1400 BROWN ET AL Ann Thorac Surg SURGERY FOR CONGENITAL AORTIC STENOSIS 2003;76:

4 Ann Thorac Surg BROWN ET AL 2003;76: SURGERY FOR CONGENITAL AORTIC STENOSIS Table 3. Preoperative, Intraoperative, and Follow-Up Aortic Valve Gradients (mm Hg) Level Preoperative Intraoperative Follow-up Valvar months of age 6 months of age Supravalvar Subvalvar Discrete Tunnel Multiple Total Values are mean SD. In 141 children undergoing aortic valvotomy through the aortic route, a slit-like orifice was usually encountered, and one or more fused commissures were incised. Nodules on the leaflets were excised if present. Children with discrete SAS had complete resection of the fibrous subaortic membrane (n 166). In 55 of these 166 patients (33%), a myotomy or myectomy was performed in conjunction with resection of the discrete subvalvar membrane. Ninety-two patients with SVAS underwent insertion of a simple, diamond-shaped Dacron (C.R. Bard, Covington, GA) or Gore-Tex (W.L. Gore and Assoc, Flagstaff, AZ) patch extending from the base of the noncoronary sinus of Valsalva to and above the level of supraaortic obstruction. An inverted bifurcated patch extending into the right coronary sinus as well as the noncoronary sinus was inserted in 12 patients. Nine additional children had extensive patches for most of their entire aortic arches and these children required femoral artery cannulation and a brief period of circulatory arrest for arch reconstruction. Sixty-four neonates and young infants less than 6 months with critical VAS underwent CTV: 57 had valvar stenosis and 7 had multiple level stenosis. Following 1401 median sternotomy (n 41) or left thoracotomy (n 23), the LV apex was elevated out of the pericardium and a moist sponge was placed behind the heart; a mattress suture of 4-0 polypropylene with a 3 7-mm Pledget was placed around the LV apex. A stab wound was made in the LV apex, and a Gruntzig balloon catheter (n 13) or serial Hegar dilators (n 51) were passed into the left ventricle and guided through the stenotic aortic valve using digital palpation of the aortic root. Progressive dilation was carried out with successive dilators stopping either at the aortic annulus diameter or 1 mm larger based on preoperative echo (range 5 to 8 mm). Since 1999 we have performed CTV under transesophageal echocardiographic guidance and have stopped dilation when mild aortic valvar regurgitation is produced. Twenty-seven neonates or young infants less than 6 months underwent open transaortic valvotomy using standard cardiopulmonary bypass through a median sternotomy. The frequently encountered severely dysplastic neonatal aortic valve was opened with a scalpel or spread with a hemostat. The aorta in these infants was closed using a single layer of fine running absorbable monofilament suture. Hypothermia and cardioplegia were used routinely in this group even though the periods of ischemia were usually less than 15 minutes. The 22 patients between 1978 and 1992 who required insertion of an AAC for tunnel subaortic stenosis had a porcine (Hancock-Extracorporeal; n 20) or St. Jude (n 2) Dacron-valved conduit placed between the apex of the left ventricle and the descending thoracic aorta by a closed technique described previously [10]. Since 1993 the Ross-Konno procedure has replaced the AAC operation in children at our institution. Initial aortic valve replacement (AVR) was performed in only 26 of 508 patients (5%). Mechanical aortic prostheses were used in 10 patients: Bjork-Shiley aortic prostheses (Shiley Laboratories, Irvine, CA) in 3 patients, the St. Jude aortic prostheses (St. Jude Medical Inc, St. Paul, MN) in 6 patients, and a Medtronic-Hall valve (Medtronic Inc, Minneapolis, MN) in 1 patient. One CARDIOVASCULAR Table 4. Number of Initial Surgical Procedures Performed in 508 Children With Congenital Aortic Stenosis Procedure SVAS VAS SAS MULTI Open valvotomy (age 6 months/ 6 months) (141/27) 0 50 (50/0) Closed transventricular valvotomy Subaortic fibrous membrane resection Subaortic fibromuscular resection Patch aortoplasty Inverted bifurcated patch with extensive endarterectomy Konno procedure AAC insertion AVR (mechanical/ross/ah) 0 17 (6/11/0) 1 (1/0/0) 8 (3/4/1) Extensive aortic arch repair Total a 171 a 212 a a Some patients had two or three initial procedures. AAC apical aortic conduit; AH aortic homograft; AVR aortic valve replacement; MULTI multilevel aortic stenosis; SAS subvalvar aortic stenosis; SVAS supravalvar aortic stenosis; VAS valvar aortic stenosis.

5 CARDIOVASCULAR 1402 BROWN ET AL Ann Thorac Surg SURGERY FOR CONGENITAL AORTIC STENOSIS 2003;76: Table 5. Number of Initial and Redo Aortic Valve Replacements Performed in 98 Children With Congenital Aortic Stenosis Procedure Initial Redo Total analysis and analysis of freedom from reoperation. Multiple regression analysis was performed as conditional backward stepwise proportional hazards regression. All p values of 0.05 were considered significant. Ross procedure Mechanical prosthesis St. Jude Medical Bjork-Shiley Medtronic Carbomedics Starr Edwards Biologic prosthesis Hancock porcine Carpantier-Edwards porcine Aortic homograft Total patient had an aortic homograft (CryoLife Inc, Kennesaw, GA) inserted in Since 1993, all 15 initial AVRs were performed using a pulmonary autograft (Ross procedure). All patients undergoing the Ross procedure had right ventricular outflow tract reconstruction performed with a pulmonary homograft (CryoLife Inc). One hundred nine (26 initial and 83 redo) AVRs have been performed in 98 children as initial or redo operations. The type of prostheses used is shown in Table 5. Ten Ross-Konno procedures have been performed as redo procedures. The results of AVR in children comparing the Ross with mechanical and other bioprostheses have been reported previously and are given in Tables 6 and 7 [11]. Statistical Analysis The statistical program SPSS for Windows version 10 (SPSS, Inc, Chicago, IL) was used for data analysis. Data are expressed as means and ranges. The Kaplan Meier product limit method and Cox proportional hazards regression methods were used for actuarial survival Results The patient s operative records were reviewed retrospectively. A clinical examination including echocardiography and electrocardiogram was performed at our institution on identified survivors. Left ventricular-aortic gradients were determined. The functional status was assigned according to the NYHA classification. The overall mean follow-up was years (median 7.0 years; range 0.5 to 41 years). Follow-up was complete in 95% of surviving patients representing a total 3,402 patients-years. Overall survival estimated by the Kaplan Meier method including early mortality in all children, was 89% at 5 years and 88% at 20, 30, and 40 years (Fig 2A). Overall freedom from reoperation estimated by the Kaplan Meier method in all children was 75% at 10 years, 65% at 20 years, 63% at 30 years, and 62% at 40 years (Fig 3A). Valvar Aortic Stenosis Two hundred forty-two children have undergone aortic valvotomy at our institution with an operative mortality of 13% (31 of 242). All but 2 of the early deaths occurred in neonates. Aortic valvotomy ( 6 months of age) carried a 34% operative mortality (29 of 85) and were responsible for 73% (29 of 40) of all early deaths in the series of 508 patients. Children more than 6 months old with aortic valvotomy or AVR had a 1% operative mortality (2 of 157). Neonates and infants less than 6 months who underwent open or closed valvotomy in the period from 1971 to 1986 had a 61% operative mortality (20 of 33). The early, late, and overall mortalities segregated by group is shown in Table 8. Since 1986 the operative mortality for closed aortic valvotomy in a neonate was 17% (9 of 52). No operative mortality has occurred in a child older than Table 6. Results of Ross Aortic Valve Replacement in Children First Author (Location) [Reference] Year No. of Patients (Procedure) Early Mortality Late Redo Cartier (Quebec, Canada) [12] (Ross) 1 (2) 0 1 (2) Reddy (San Francisco, CA) [13] (Ross) 2 (4) 0 2 (4) Jones (Seattle, WA) [14] (Ross) (Allograft) 1 (13) Walters (Detroit, MI) [15] (Ross) 0 1 (3) 1 (3) Durham (Ann Arbor, MI) [16] (Ross) (2) Najm (Toronto, Canada) [17] (Ross) 2 (25) 0 1 (13) 22 (Allograft) 3 (14) 1 (5) 0 Simon (Vienna, Austria) [18] (Ross) 0 1 (3) 1 (3) Laudito (San Francisco, CA) [19] (Ross) (10) Elkins (Oklahoma, OK) [20] (Ross) 8 (5) 3 (2) 12 (7) Brown (Indianapolis, IN) [current study] (Ross) 1 (2) 1 (2) 2 (4) Mortality and redo values are n (%).

6 Ann Thorac Surg BROWN ET AL 2003;76: SURGERY FOR CONGENITAL AORTIC STENOSIS Table 7. Results of Mechanical and Heterograft Aortic Valve Replacement in Children First Author (Location) [Reference] Year No. of Patients (Type of Prosthesis) Early Mortality Late 1403 Redo CARDIOVASCULAR Moodie (Cleveland, OH) [21] (Mechanical) (8) 7 (Tissue) (43) Schoof (Rotterdam, Netherlands) [22] (Mechanical) 0 1 (7) 1 (7) Champsaur (Lyon, France) [23] (Mechanical) 7 (13) 6 (11) 3 (6) Lupinetti (Seattle, WA) [24] (Mechanical) 3 (12) 0 2 (8) Mazzitelli (Munich, Germany) [25] (Mechanical) 2 (4) 1 (3) 5 (17) 8 (Tissue) (50) Alexiou (Southampton, UK) [26] (Mechanical) 3 (5) 3 (5) 5 (9) Brown (Indianapolis, IN) [current study] (Mechanical) 0 3 (9) 4 (12) 6 (Tissue) (50) Mortality and redo values are n (%). 2 months of age since 1975, regardless of the operative technique. Patients Younger Than 6 Months Old With Valvar Aortic Stenosis Ninety-three patients less than 6 months of age have undergone surgical procedures for AS. Eight patients had multilevel obstruction and were excluded from this group and were included in the multilevel LVOTO group. There were 29 early deaths (29 of 85, 34%): 11 patients with open valvotomy and 18 patients with CTV. Seven of the 8 patients operated on before 1978 by open aortic valvotomy on cardiopulmonary bypass died. After 1978 we adopted the CTV approach in patients younger than 8 weeks. The mortality for CTV since 1985 was 9 of 52 (17%) in a group with a mean age of 6 to 8 days. The operative mortality during the same time period with open valvotomies was 0%, but the mean age of the infants was 3 months reflecting an older, more stable group with less dysplastic valves. Forty-nine of the 55 hospital survivors (89%) included in critical AS group ( 6 months) have a mean follow-up of years; the longest has been followed 22 years. There were 6 late deaths (all 3 to 4 months postoperatively, Table 8): 2 deaths were due to chronic liver failure, Fig 2. Actuarial patient survival, including operative mortality in patients with congenital aortic stenosis. (A) Survival in all patients with congenital aortic stenosis. (B) Actuarial survival in patients with valvar aortic stenosis. patients 6 months of age; patients 6 months of age. (C) Actuarial survival according to level of obstruction. valvar aortic stenosis (VAS); supravalvar aortic stenosis (SVAS); Πsubvalvar aortic stenosis (SAS); multilevel aortic stenosis (MULTI).

7 CARDIOVASCULAR 1404 BROWN ET AL Ann Thorac Surg SURGERY FOR CONGENITAL AORTIC STENOSIS 2003;76: Fig 3. Actuarial freedom from reoperation (%) in patients with congenital aortic stenosis. (A) All patients with congenital aortic stenosis. (B) Patients with valvar aortic stenosis. patients 6 months of age; patients 6 months of age. (C) According to level of obstruction. valvar aortic stenosis; supravalvar aortic stenosis; Πsubvalvar aortic stenosis; multilevel aortic stenosis. 1 was due to pulmonary hypertension, and 2 were sudden and of unknown cause. The sixth patient was a 2-day-old neonate with a small left ventricle who underwent CTV that was complicated by perforation of the posterior aspect of the ascending aorta. Bleeding in this patient required placement on cardiopulmonary bypass and repair of the aortic root. The patient required extracorporeal membrane oxygenation (ECMO) support because of severe LV diastolic dysfunction before and after CTV. The patient was weaned from ECMO and was stable, although he could not be weaned from ventilatory support. An echocardiogram showed a residual gradient of approximately 25 mm Hg across the aortic valve and moderate aortic regurgitation. Orthotopic cardiac trans- Table 8. Etiology of Early and Late Mortality in All Patients With Aortic Stenosis Cause of Death Early Deaths (n) Late Deaths (n) VAS SVAS SAS MULTI VAS SVAS SAS MULI Cardiac Low output cardiac failure Massive cerebral bleeding Sepsis, renal failure Arrhythmia Pulmonary hypertension Unexplained/unknown Liver failure Noncardiac Total MULTI multilevel aortic stenosis; SAS subvalvar aortic stenosis; SVAS supravalvar aortic stenosis; VAS valvar aortic stenosis.

8 Ann Thorac Surg BROWN ET AL 2003;76: SURGERY FOR CONGENITAL AORTIC STENOSIS Table 9. Results of Surgical Aortic Valvotomy in Neonates First Author (Location) [Reference] Year No. of Patients Age (months) Technique Mortality (%) Mocellin (Munich, Germany) [27] Open in Brown (Indianapolis, IN) [1] Open 67 Closed 53 Karl (Melbourne, Australia) [28] Open 31 Mosca (Ann Arbor, MI) [29] Closed in Balloon in Gaynor (Philadelphia, PA) [30] Closed in (overall) Open in 47 Balloon in 12 Hawkins (Salt Lake City, UT) [31] Open 11 Alexiou (Southampton, UK) [32] Open 0 Brown (Indianapolis, IN) [current study] Closed in (overall) 1 to 4 Open in CARDIOVASCULAR plantation was performed, but this child died due to low cardiac output several days later secondary to pulmonary hypertension and graft failure. Overall survival estimated by the Kaplan Meier method including early mortality was 59% at 5, 10, 15, and 20 years (Fig 2B). Since 1985, the survival has been 85% (62/85). Five risk factors were significant on univariate analysis: presence of endocardial fibroelastosis (p 0.05); presence of hypoplastic LV (p 0.003); complexity of the disease (p 0.04); aortic valve annulus of less than 5.0 mm (p 0.01); and surgery before 1978 (p 0.001). Of these five factors, only the presence of a hypoplastic LV (p 0.001) and surgery before 1978 (p 0.001) remain significant by multivariate analysis. The mean preoperative aortic pressure gradient decreased from mm Hg to mm Hg after surgery (p 0.012). Twenty-five of 45 patients (55%) had postoperative gradients of more than 35 mm Hg, and 17 of 45 patients (38%) had late postoperative gradients of more than 50 mm Hg at last follow-up. Aortic insufficiency (AI) was not documented before surgery; however, 34 of 45 patients (76%) had documented AI on late follow-up: it was mild in 47% (16 of 34), moderate in 32% (11 of 34), and severe in 21% (7 of 34) of patients. Sixteen reoperations have been performed in 14 patients (14 of 55, 26%). The predominant indication for reoperation was the presence of combined stenosis with AI (9 of 14, 64%) followed by restenosis (4 of 14, 29%) or pure AI (1 of 14, 7%). One of these patients also had an aneurysm of ascending aorta. One patient required a second and a third procedure (7 and 13 years after initial surgery). Nine patients eventually required a Ross procedure, 2 had AVR with mechanical valves, 2 had repeat open valvotomies, and 1 patient had a heart transplant. The mean time from initial surgery to first reoperation was years (range 3 months to 17 years). Overall freedom from reoperation estimated by the Kaplan Meier method was 91% at 5 years, 82% at 10 years, 77% at 15 years, and 71% at 20 years (Fig 3B). Univariate and multivariate analysis showed the presence of CTV (p 0.02) as the best preoperative predictors of late reoperation in survivors. Forty-five patients (100%) were currently in NYHA functional class I or II. There was no atrioventricular block or pacemaker implantation in this group. A review of the results in several large series is shown in Table 9. Patients Older Than 6 Months With Valvar Aortic Stenosis One hundred fifty-seven children older than 6 months underwent surgery for isolated VAS: 141 patients (90%) underwent a standard aortic valve commissurotomy and 16 patients (10%) underwent an initial AVR: 10 patients utilizing a pulmonary autograft (Ross procedure) and 6 using a mechanical prosthesis. An additional 65 patients with multilevel LVOTO had open valvotomy (n 50), CTV (n 7) or AVR as part of their initial treatment (Table 10). There were 2 early deaths (2 of 157, 1%) that occurred in the early part of series (before 1975) and were secondary to low cardiac output. One hundred fifty-one of the 155 hospital survivors (97%) have been followed up with a mean follow-up time of years; the longest was 41 years, and 21 patients (21 of 155, 14%) were followed for more than 20 years. One hundred forty-nine patients (149 of 151, 99%) are still alive at last contact. There were 2 late deaths at 5 and 12 years after initial procedure. Both of these patients required subsequent AVR; 1 died secondary to end-stage renal disease and massive myocardial hypertrophy, and the other died of a cardiac dysrhythmia 1 year after valve replacement surgery. Overall survival estimated by the Kaplan Meier method, including early mortality, was 98% at 5 years and 97% at 20, 30, and 40 years (Fig 2B). A comparison of preoperative and immediate postoperative pressure gradients documented a decrease of the peak from mm Hg to mm Hg (p 0.004). Thirty-one patients (31 of 155, 20%) had a late postoperative gradients of more than 50 mm Hg, and 21

9 CARDIOVASCULAR 1406 BROWN ET AL Ann Thorac Surg SURGERY FOR CONGENITAL AORTIC STENOSIS 2003;76: Table 10. Number of Initial and Redo Procedures Performed in 94 Children with Multilevel Aortic Stenosis Procedure Initial Redo Total Open valvotomy Diamond-shaped patch aortoplasty Fibrous subaortic resections Fibromuscular subaortic resection Inverted bifurcated aortic patch Valve sparing Konno AVR Mechanical prosthesis Ross procedure Aortic homograft AAC Replacement of AAC Removal of AAC Closed transventricular valvotomy Heart transplantation Others Total AAC Apical aortic conduit; AVR aortic valve replacement. additional patients (21 of 155, 16%) had late postoperative gradients of more than 35 mm Hg. The mean follow-up in this subset was years. Aortic insufficiency was documented in 32 patients (32 of 157, 20%) before surgery; however, 103 patients (103 of 155, 67%) had AI documented on late follow-up: mild in 56% (58 of 103), moderate in 27% (27 of 103), and severe in 17% (17 of 103). Fifty-five reoperations were performed in 45 patients (45 of 155, 29%). The indications for reoperation were the recurrence of stenosis with insufficiency (26/45, 58%) followed by isolated restenosis (13/45, 29%) or pure insufficiency (4/45, 9%). Two patients required reoperation (both with mechanical AVR) one for profound hemolysis and anemia and the other for an ascending aorta aneurysm (n 1). Eight patients required a third aortic procedure: Ross aortic root replacement in 6 and mechanical AVR in 2. Both patients with mechanical AVR previously had undergone porcine valve insertion and were reoperated (2 and 16 years after the initial surgery) due to prosthesis degeneration. Indications for the Ross procedure were recurrent AS or severe AI in all patients. Two children had a fourth procedure: one for resection of ascending aortic aneurysm and the other for autograft valvuloplasty with resection of LV pseudoaneurysm. The mean time from initial surgery to first reoperation was years, and from first to second reoperation was years. A bicuspid valve was present in 36 patients (80%) who required reoperation; this did not differ significantly from the initial population (p 0.05). Thirty-three patients (21%) followed for more than 25 years and 15 patients (10%) followed for more than 15 years after their initial surgery have required AVR. Overall freedom from reoperation estimated by the Kaplan Meier method was 80% at 10 years, 67% at 20 years, 62% at 30 years, and 61% at 40 years (Fig 3B). One hundred forty patients (93%) are currently in NYHA functional class I or II, and 11 patients (7%) are in class III. Comparing NYHA class of reoperated and nonreoperated patients, patients who had not undergone reoperation were in a significantly better NYHA class (p 0.02) at last follow-up. Among the patients who were NYHA class III, 1 had ventricular arrhythmia, 1 had a left anterior hemi block, and 2 had atrioventricular block and had pacemaker implantation. A comparison of the results of several large series of children with VAS is shown in Table 11. Supravalvar Aortic Stenosis There was 1 hospital death (1 of 40, 2.5%) in patients who underwent repair of isolated SVAS. This resulted from postoperative cardiac failure in the early part of the series (1962). In this patient Dacron patch enlargement of the aorta had been confined to the root. Sixty-two patients with multilevel LVOTO had a patch aortoplasty for SVAS as part of their initial surgical procedure (single sinus repair, n 50; double sinus repair, n 12; Table 10). Three of these patients with single sinus repair required reoperations at a later date. Thirty-three of the 39 surviving patients with isolated SVAS (85%) were contacted within the past 2 years. The mean follow-up was years (range 6 months to 20 years). There have been no late deaths since Figure 2C shows the overall actuarial survival, including operative mortality, with 98% survival at 5, 10, 15, and 20 Table 11. Results of Surgical Treatment in Children with Valvar Aortic Stenosis First Author (Location) [Reference] Year No. of Patients Early Mortality Late Redo Salomon (Tucson, AZ) [2] (2) 10 (8) 26 (20) Wheller (Columbus, OH) [33] (5) 4 (3) 26 (22) DeBoer (Bethesda, MD) [34] (4) 9 (18) 19 (39) Chartrand (Quebec, Canada) [35] (3) 16 (24) Detter (Munich, Germany) [36] (3) 26 (22) 37 (32) Alexiou (Southampton, UK) [4] (2) 10 (3) 25 (26) Brown (Indianapolis, IN) [current study] a 9 (2) 15 (4) 135 (32) a Infants and children (without neonates). Mortality and redo values are n (%).

10 Ann Thorac Surg BROWN ET AL 2003;76: SURGERY FOR CONGENITAL AORTIC STENOSIS Table 12. Number of Initial and Redo Procedures Performed in 132 Children with Subvalvar Aortic Stenosis Procedure Initial Redo Total Fibrous subaortic resections Fibromuscular subaortic resection Fibrous subaortic resections and fibromuscular subaortic resection AAC Replacement of AAC Removal of AAC Fibrous subaortic resections and AAC Fibrous subaortic resections and AVR (mechanical) Fibrous subaortic resections and Konno Valve-sparing Konno Ross procedure Heart transplantation AVR (mechanical/ah) 0 2/1 3 Total AAC apical aortic conduit; AH aortic homograft; AVR aortic valve replacement. years. Univariate and multivariate analysis identified none of the tested variables as risk factors for death. The mean preoperative aortic pressure gradient decreased from mm Hg to mm Hg (p 0.001). Four patients (10%, 4 of 39) had postoperative gradients of more than 35 mm Hg, and 2 of these patients had postoperative gradients of more than 50 mm Hg at last follow-up. Aortic insufficiency was documented in 2 patients (2 of 40, 5%) before initial operation; it was documented in 7 patients (7 of 33, 21%) on late follow-up: AI was mild in 86% (6 of 7) and moderate in 1 (14%, 1 of 7). Three reoperations were performed in 3 patients (3 of 39, 8%). Two patients with recurrent SVAS underwent redo patch aortoplasty (2 and 10 years after initial surgery), and the third patient with recurrent SVAS and moderate AI underwent a Ross procedure (11 years after initial surgery). Risk factor for reoperation by univariate analysis was the presence of late LV-aortic gradient of more than 35 mm Hg (p 0.05). Overall freedom from reoperation estimated by the Kaplan Meier method was 97% at 5 years, 95% at 10 years, and 92% at 20 years (Fig 3C). Postoperatively, all patients were in NYHA class I and II. Recent echocardiographic follow-up showed the persistence of mild stenosis of the pulmonary artery branches in 2 patients with initial severe pulmonary branch stenosis that were repaired by patch enlargement at the time of initial SVAS surgery. Much of the data on this subset of patients with SVAS were previously published [9]. Subvalvar Aortic Stenosis One hundred thirty-two patients (132 of 508, 24%) with isolated SAS have undergone surgical procedures. There were 110 patients (110 of 132, 83%) with discrete subaortic 1407 membrane and 22 patients (22 of 132, 17%) with diffuse tunnel-like fibromuscular obstruction. All the surgical procedures performed for SAS are shown in Table 12. An additional 73 patients had surgery for SAS as a part of their treatment for multilevel LVOTO (fibrous resection, n 37; fibromuscular resection, n 29; valve-sparing Konno, n 7) (Table 10). There were 5 early deaths (5 of 132, 4%) that occurred in patients with isolated discrete SAS and 1 patient with tunnel SAS (1 of 132, 0.8%). Three of the 5 deaths in patients with discrete membrane occurred in the early part of our experience (1960 to 1963). Five of 6 early deaths were secondary to low cardiac output. One patient died because of renal failure. One hundred twenty patients of the 126 hospital survivors (95%) were contacted within the past 2 years. The mean follow-up was years (range 6 months to 29 years). There were 8 late deaths (8 of 132, 6%): 2 patients with discrete SAS and 6 patients with tunnel type SAS. The 2 late deaths in patients with discrete SAS were of cardiac origin: 1 due to cerebrovascular accident (3 months after surgery) and 1 with congestive heart failure (7 years after surgery). Causes of the 6 late deaths in tunnel SAS group were as follows: 3 were from low cardiac output (1, 2, and 3 years after surgery, respectively); 1 was sudden of unexplained cause 5 years after repair; and 2 were related to noncardiac causes (1 due to hemoptysis 4 years after operation, and 1 due to aspiration and respiratory arrest 6 months after reoperation). Overall survival including early and late mortality was 90% at 5 years and 89% at 25 years (Fig 2C). Univariate and multivariate analysis identified date of operation (before 1975) as a risk factor for death (p 0.002). The mean preoperative aortic pressure gradient decreased from mm Hg to mm Hg (p 0.002). No significant difference was noted in the mean preoperative LV-aortic gradients of the discrete ( mm Hg) and diffuse groups of patients with SAS ( mm Hg; p 0.12). Although, the late mean postoperative LV-aortic gradient was better for the patients with discrete SAS ( mm Hg) than for the patients with diffuse type of SAS ( mm Hg; p 0.02). Likewise, the proportion of patients with late postoperative LVOT gradients of more than 50 mm Hg was significantly greater in patients with tunnel obstruction (7 of 13, 54%) than for those with discrete obstruction (16 of 94, 16%; p 0.001). Mild AI was documented in 20 patients (20 of 132, 15%) before surgery, and 31 patients had AI on late follow-up (31 of 107, 29%; p 0.055). The AI was mild in 84% (26 of 31), moderate in 13% (4 of 31), and severe in 3% (1 of 31) of patients. Thirty reoperations were performed in 25 surviving patients (25 of 120, 21%): 10 patients with discrete SAS required reoperations, as did 15 patients with diffuse SAS. The mean time from initial surgery to first reoperation was years (range 5 months to 25 years). Three patients underwent second reoperation (mean years) and 2 patients underwent a third reoperation (mean years). The predominant indication for reoperation was the presence of recurrent subaortic ste- CARDIOVASCULAR

11 CARDIOVASCULAR 1408 BROWN ET AL Ann Thorac Surg SURGERY FOR CONGENITAL AORTIC STENOSIS 2003;76: nosis with AI (12 of 30, 40%), isolated recurrent subaortic stenosis (12 of 30, 40%), or pure AI (1 of 30, 3%). Two patients with cardiomyopathy required heart transplantation. Six patients who required an AAC initially underwent removal of the AAC due to stenosis or thrombosis (n 4) or pseudoaneurysm at the LV anastomosis (n 2). Two underwent late insertion of an AAC after an initial attempt to relieve SAS directly. An AVR was performed with pulmonary autograft in 5 patients (1 of them with Konno procedure), a mechanical prosthesis in 2 patients, and an aortic homograft in 1 patient. A repeat resection of subaortic membrane was performed in 10 patients (7 of them with myotomy and myectomy). Two patients required a valve-sparing Konno procedure. Overall freedom from reoperation was 90% at 5 years, 79% at 10 years, 76% at 25 years (Fig 3C). Statistical analysis revealed that several factors could be predictors for recurrence of the SAS. In univariate analysis anatomic, surgical, and hemodynamic factors were strong predictors for recurrence. The anatomic factor was relative hypoplasia of aortic annulus less than 5 mm (p 0.05). The presence of AAC (p 0.02), and higher preoperative gradients across the LVOT (p 0.04) were associated with higher rates for reoperation. The independent risk factors for reoperation by Cox multivariate regression analysis were AAC insertion (p 0.005) and a late follow-up gradients of mm Hg in patients with tunnel SAS (p 0.004). Of the 120 patients with SAS in this study followed postoperatively, 100 patients had the discrete type of SAS and 20 patients had the diffuse type of SAS. No significant difference was noted between the groups in preoperatively functional class. However, postoperatively the patients with the discrete form of SAS were in a better functional class (88 in class I and 12 in class II) than the patients with the tunnel-type of SAS (12 in class I, 6 in class II, and 2 in class III; p 0.01). Multilevel of Left Ventricular Outflow Tract Obstruction Ninety-four patients presented with multiple levels of LVOTO had a combination of surgical techniques. The total number of initial and redo procedures performed in these 94 patients was 212 (Table 10). Eight patients with multilevel obstruction were neonates and had neonatal critical AS as part of their LVOTO. The only early death (1 of 94, 1.1%) occurred in a 1-month-old infant who underwent a Ross-Konno procedure with an extensive aortic arch patch, atrial septal defect, and ventral septal defect closure. The death was due to intercerebral bleeding during the weaning process from ECMO support 5 days after this extensive and complex repair. Ninety-two of the hospital survivors (99%) were contacted within the past 2 years. The mean follow-up was years (range 6 months to 23 years). There were 5 late deaths (range 3 months to 4 years). One patient with localized SVAS and valvar aortic stenosis underwent total aortic root replacement with an aortic homograft at another institution and died 3 years after the initial conservative operation. A second late death occurred in a patient with residual SVAS and tunnel subaortic stenosis. The operative procedure for insertion of the AAC and the hospital course were unremarkable. This patient was discharged on the 14th postoperative day but returned 3 weeks later with fever and left pleural effusion. Although the pleural fluid was sterile initially, it became secondarily infected and led to a staphylococcal empyema. The infected AAC conduit was removed, and an aortoventriculoplasty (Konno procedure) was performed. The patient died of renal failure and continued sepsis 2 weeks after reoperation. The third death occurred in a child with recurrent SAS and SVAS. The death occurred 6 months postoperatively due to arrhythmia. A 19-year-old patient with severe subvalvar and valvar LVOTO became the fourth death. This patient had originally undergone resection of subvalvar membrane and open valvotomy at the age of 8 years. Eleven years later this patient underwent insertion of an AAC due to recurrent diffuse SAS. Recovery was uneventful, but 4 years later the patient died of a sudden pulmonary hemorrhage. The fifth death occurred 6 month after surgery of unknown cause. Overall survival estimated by the Kaplan Meier method including early mortality, was 95% at 5, 10, 15, and 20 years (Fig 2C). The mean preoperative aortic pressure gradient decreased from mm Hg to mm Hg (p 0.02) intraoperatively. Fourteen patients (14 of 75, 19%) had late postoperative gradients of more than 50 mm Hg, and 5 additional patients (5 of 75, 7%) had late postoperative gradients of more than 35 mm Hg. Aortic insufficiency was documented in 6 patients (6 of 94, 6%) before surgery; and 40 patients (40 of 75, 53%) had documented AI on late follow-up. In 27 it was mild (27 of 40, 67%), moderate in 9 (9 of 40, 23%), and severe in 4 (4 of 40, 10%). Forty-seven reoperations were performed in 34 patients (34 of 93, 37%) (Table 10). The mean time from initial surgery to first reoperation was years (range 3 months to 22 years). Nine patients underwent second reoperation (mean years; range 3 months to 16 years), and 4 patients underwent a third reoperation (mean years; range 1 to 10 years). All patients with neonatal critical AS (n 7) as part of their multilevel AS underwent reoperation years after the initial procedure. The predominant indication for reoperation was presence of recurrent SAS with AI (32%, 15 of 47) and recurrent SAS (45%, 21 of 47), or pure AI (6%, 3 of 47 of reoperations). One patient with a cardiomyopathy required heart transplantation. Six patients underwent insertion of an AAC and 6 more patients with AAC underwent removal or revision of their AAC for the following reasons: 2 were revised for AAC valve regurgitation and 4 were removed or ligated for AAC thrombosis. In 17 patients, an AVR was performed by the following techniques: 13 Ross AVRs, 3 Ross-Konno AVRs and one aortic homograft AVR. A repeat resection of a subaortic membrane was performed in 6 patients (1 with myotomy and myectomy). Four patients underwent repeat open valvotomy, 2 patients underwent aortic valvu-

12 Ann Thorac Surg BROWN ET AL 2003;76: SURGERY FOR CONGENITAL AORTIC STENOSIS loplasty due to severe AI, 1 patient had resection of an LV pseudoaneurysm, and 1 patient underwent resection of an ascending aortic pseudoaneurysm. Three patients required a valve-sparing Konno procedure. Overall freedom from reoperation estimated by the Kaplan Meier method was 66% at 5 years, 53% at 10 years, 40% at 20 years, and 39% at 25 years (Fig 3C). Statistical analysis revealed that several factors were predictors for reoperation in patients with multilevel LVOTO. In univariate analysis anatomic and surgical factors were strong predictors for the need for reoperation. Valvotomy for neonatal critical AS was a strong predictor for reoperation (p ), as was apico-aortic conduit insertion (p 0.005). In the multivariate Cox regression analysis AAC insertion (p ) and the diagnosis of neonatal critical AS in infant less than 6 months (p 0.002) were independent risk factors for reoperation. At latest clinical evaluation, all survivors (n 92) were in NYHA functional class I and II leading normal or near-normal lives. Comment The results of this retrospective analysis of 668 procedures in 508 consecutive patients with congenital LVOTO substantiate the general safety and efficacy of surgical therapy for congenital aortic stenosis. In most instances operation can be performed with a low mortality (8% in our entire series, 2% mortality excluding neonates and infants 6 months) and a high probability of successful outcome. This and other recent reports emphasize the palliative nature of operative intervention for VAS (Table 11) [2, 36, 37]. With increasingly longer follow-up, a greater proportion of patients with valvar and multilevel AS will come to reoperation [36]. At 20 years after their initial operation, 27% of the surviving patients in our entire series had undergone a subsequent operative procedure (valvar: 59 of 242, 24%; multilevel AS: 34 of 94, 36%). Detter and colleagues [36] reoperated on 32% of their patients within a mean of 18 years after initial surgical intervention. These findings compare well with the 39% requiring reoperation at a mean of 17.7 years postoperatively reported by DeBoer and colleagues [34] and reflects the effectiveness of aortic valvotomy in children with the adequate relief of high LVOT gradients. Two high-risk subgroups for recurrence and reoperation have been clearly identified. The group with the highest early mortality was the neonate and infant group less than 6 months of age [31]. The significantly higher mortality reflects several factors. First, these infants manifest severely symptomatic congestive heart failure. Second, associated cardiac anomalies more commonly affect both early and late results, especially in children with borderline hypoplastic left ventricles and endocardial fibroelastosis. Third, operative repair is often more difficult and less precise than in older patients because the neonatal valves are frequently dysplastic. This group represents one of the most challenging facets of congenital AS, and although operative methods are generally 1409 well standardized, a wide variety of surgical approaches have been advocated. We have found that transventricular closed aortic valvotomy without bypass has worked as well as or better than any other surgical or balloon valvotomy method in our neonates with critical AS (Table 9). The long-term results with respect to survival and reoperation are good and compare favorably with other forms of neonatal treatment for critical AS. Neonates with evidence of severe aortic annulus hypoplasia, low ejection fraction, and endocardial fibroelastosis are not good candidates for surgical valvotomy and should be considered for a univentricular repair (ie, Norwood). We consider most procedures performed in neonates are palliative and reintervention is usually required within 10 years. Further long-term follow-up or perhaps a randomized trial will be needed to determine accurately which therapy (ie, transventricular valvotomy, open valvotomy, balloon aortic valvuloplasty, or even neonatal Ross-Konno procedure) will have the best longterm outcome for critical AS in the neonate and infants less than 6 months. The other patient group at considerably higher risk for reoperation is the group with multilevel LVOTO. The choice of the first or second surgical procedure will be determined by the location and anatomy of the LVOTO and by the patient s age and size. The Ross AVR, the Ross-Konno procedure, and the valve-sparing Konno procedure are all techniques that appear to have the long-term ability to relieve LVOT pathology. The AAC procedure performed at our institution between 1979 and 1992 provided good palliation for 25 children. There were 2 early and 8 late deaths; however, 2 patients were lost to follow-up. Eleven patients underwent removal or revisions of AAC due to degenerative insufficiency of the conduit porcine valve stenosis or thrombosis of AAC prosthesis. Four subsequently had a Ross or Ross-Konno procedure. Two patients still have their original AAC, 22 and 23 years after initial implantation, but both have had the porcine valves replaced with a mechanical prosthesis 11 years after initial AAC insertion. Our data demonstrated that the AAC was effective in relieving complex LVOTO and improvement in LV performance with acceptable midterm results [38]. Since the early 1990s the AAC procedure has been largely replaced with the Ross or Ross-Konno procedure in our practice. The AAC procedure continues to have a role in older adult patients with critical AS in whom a direct approach through median sternotomy is unattractive (ie, calcified egg shell ascending aorta, prior sternal wound infection, or multiple patent arterial or venous bypass grafts). Valvotomy of the bicuspid or tricuspid aortic valves in children has several advantages over early valve replacement. It relieves most of the obstruction and preserves the native valve and offers 10 to 20 years with low reoperative rates and low thromboembolic rates without anticoagulation. As a result VAS can be surgically palliated in children until they reach adolescence or adulthood [35]. During this time, the aortic annulus will grow sufficiently in most cases to accommodate a prosthesis of CARDIOVASCULAR

LEFT VENTRICULAR OUTFLOW OBSTRUCTION WITH A VSD: OPTIONS FOR SURGICAL MANAGEMENT

LEFT VENTRICULAR OUTFLOW OBSTRUCTION WITH A VSD: OPTIONS FOR SURGICAL MANAGEMENT LEFT VENTRICULAR OUTFLOW OBSTRUCTION WITH A VSD: OPTIONS FOR SURGICAL MANAGEMENT 10-13 March 2017 Ritz Carlton, Riyadh, Saudi Arabia Zohair AlHalees, MD Consultant, Cardiac Surgery Heart Centre LEFT VENTRICULAR

More information

14 Valvular Stenosis

14 Valvular Stenosis 14 Valvular Stenosis 14-1. Valvular Stenosis unicuspid valve FIGUE 14-1. This photograph shows severe valvular stenosis as it occurs in a newborn. There is a unicuspid, horseshoe-shaped leaflet with a

More information

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)

More information

Long-term results (22 years) of the Ross Operation a single institutional experience

Long-term results (22 years) of the Ross Operation a single institutional experience Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department

More information

The pulmonary valve is the most common heart valve

The pulmonary valve is the most common heart valve Biologic versus Mechanical Valve Replacement of the Pulmonary Valve After Multiple Reconstructions of the RVOT Tract S. Adil Husain, MD, and John Brown, MD Indiana University School of Medicine, Department

More information

Treatment of congenital aortic valve disease: Neonatal surgical management. Pascal Vouhé - Sick Children Hospital, Paris

Treatment of congenital aortic valve disease: Neonatal surgical management. Pascal Vouhé - Sick Children Hospital, Paris Treatment of congenital aortic valve disease: Neonatal surgical management Pascal Vouhé - Sick Children Hospital, Paris Challenges. valvar lesions. associated lesions. status of left ventricle Valvar lesions.

More information

The Ross-Konno Procedure in Children: Outcomes, Autograft and Allograft Function, and Reoperations

The Ross-Konno Procedure in Children: Outcomes, Autograft and Allograft Function, and Reoperations The Ross-Konno Procedure in Children: Outcomes, Autograft and Allograft Function, and Reoperations John W. Brown, MD, Mark Ruzmetov, MD, PhD, Palaniswamy Vijay, MPH, PhD, Mark D. Rodefeld, MD, and Mark

More information

PPM: How to fit a big valve in a small heart

PPM: How to fit a big valve in a small heart PPM: How to fit a big valve in a small heart Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC King Abdulaziz Cardiac Centre National Guard Health Affairs Riyadh, Saudi Arabia GHA meeting Muscat

More information

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

Management of Difficult Aortic Root, Old and New solutions

Management of Difficult Aortic Root, Old and New solutions Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult

More information

Introduction. Study Design. Background. Operative Procedure-I

Introduction. Study Design. Background. Operative Procedure-I Risk Factors for Mortality After the Norwood Procedure Using Right Ventricle to Pulmonary Artery Shunt Ann Thorac Surg 2009;87:178 86 86 Addressor: R1 胡祐寧 2009/3/4 AM7:30 SICU 討論室 Introduction Hypoplastic

More information

The Rastelli procedure has been traditionally used for repair

The Rastelli procedure has been traditionally used for repair En-bloc Rotation of the Truncus Arteriosus A Technique for Complete Anatomic Repair of Transposition of the Great Arteries/Ventricular Septal Defect/Left Ventricular Outflow Tract Obstruction or Double

More information

An anterior aortoventriculoplasty, known as the Konno-

An anterior aortoventriculoplasty, known as the Konno- The Konno-Rastan Procedure for Anterior Aortic Annular Enlargement Mark E. Roeser, MD An anterior aortoventriculoplasty, known as the Konno-Rastan procedure, is a useful tool for the cardiac surgeon. Originally,

More information

The Ross Procedure: Outcomes at 20 Years

The Ross Procedure: Outcomes at 20 Years The Ross Procedure: Outcomes at 20 Years Tirone David Carolyn David Anna Woo Cedric Manlhiot University of Toronto Conflict of Interest None The Ross Procedure 1990 to 2004 212 patients: 66% 34% Mean age:

More information

Case. 15-year-old boy with bicuspid AV Severe AR with moderate AS. Ross vs. AVR (or AVP)

Case. 15-year-old boy with bicuspid AV Severe AR with moderate AS. Ross vs. AVR (or AVP) Case 15-year-old boy with bicuspid AV Severe AR with moderate AS Ross vs. AVR (or AVP) AMC case 14-year-old boy with bicuspid AV Severe AS with mild AR Body size Bwt: 55 kg, Ht: 154 cm, BSA: 1.53 m 2 Echocardiography

More information

Long-term results of a strategy of aortic valve repair in the paediatric population: Should we avoid cusp extension?

Long-term results of a strategy of aortic valve repair in the paediatric population: Should we avoid cusp extension? Long-term results of a strategy of aortic valve repair in the paediatric population: Should we avoid cusp extension? Y d Udekem, J Siddiqui, C Seaman, I Konstantinov, J Galati, M Cheung, C Brizard Royal

More information

Surgical treatment of congenital valvular

Surgical treatment of congenital valvular Thorax (1976), 31, 398. Surgical treatment of congenital valvular aortic stenosis LUIGI CHIARIELLO, PETER VLAD, and S. SUBRAMANIAN Departments of Paediatric Cardiology and Cardiovascular Surgery, Children's

More information

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,

More information

Since the Ross procedure was first described in 1967

Since the Ross procedure was first described in 1967 Ross-Konno Procedure With Mitral Valve Surgery Norihiko Oka, MD, PhD, Osman Al-Radi, MD, Abdullah A. Alghamdi, MD, Siho Kim, MD, and Christopher A. Caldarone, MD Division of Cardiovascular Surgery, The

More information

Critical Aortic Stenosis in Early Infancy: Surgical Treatment for Residual Lesions After Balloon Dilation

Critical Aortic Stenosis in Early Infancy: Surgical Treatment for Residual Lesions After Balloon Dilation Critical Aortic Stenosis in Early Infancy: Surgical Treatment for Residual Lesions After Balloon Dilation Vladimiro L. Vida, MD, Tomaso Bottio, MD, Ornella Milanesi, MD, Elena Reffo, MD, Roberta Biffanti,

More information

S plex of parachute mitral valve, supravalvar ring of the. Shone s Anomaly: Operative Results and Late Outcome

S plex of parachute mitral valve, supravalvar ring of the. Shone s Anomaly: Operative Results and Late Outcome Shone s Anomaly: Operative Results and Late Outcome Steven F. Bolling, MD, Mark D. Iannettoni, MD, Macdonald Dick 11, MD, Amnon Rosenthal, MD, and Edward L. Bove, MD Sections of Thoracic Surgery and Pediatric

More information

In 1980, Bex and associates 1 first introduced the initial

In 1980, Bex and associates 1 first introduced the initial Technique of Aortic Translocation for the Management of Transposition of the Great Arteries with a Ventricular Septal Defect and Pulmonary Stenosis Victor O. Morell, MD, and Peter D. Wearden, MD, PhD In

More information

Excellence in heart and lung care. Royal Brompton Hospital, Sydney Street, London SW3 6NP

Excellence in heart and lung care. Royal Brompton Hospital, Sydney Street, London SW3 6NP The Surgical Management of the Bicuspid Aortic Valve in Children Professor D.F Shore Royal Brompton & Harefield NHS Trust Excellence in heart and lung care Royal Brompton Hospital, Sydney Street, London

More information

S. Bert Litwin, MD. Preface

S. Bert Litwin, MD. Preface Preface Because of the wide variety of anomalies encountered in congenital heart surgery, a broad understanding of the pathologic anatomy of defects is vitally important to the surgeon. More than in many

More information

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty

More information

Hypoplasia of the aortic root1 The problem of aortic valve replacement

Hypoplasia of the aortic root1 The problem of aortic valve replacement Hypoplasia of the aortic root1 The problem of aortic valve replacement ROWAN NICKS, T. CARTMILL, and L. BERNSTEIN Department of Cardio-thoracic Surgery and the Hallstrom Institute of Cardiology, the Royal

More information

Left Ventricular Outflow Tract Anomalies

Left Ventricular Outflow Tract Anomalies Left Ventricular Outflow Tract Anomalies 3 Contents Introduction 95 Aortic Stenosis in Neonates and Infants 95 Anatomy 95 Indication for Surgery 96 Approach and Cardiopulmonary Bypass Strategy 96 Open

More information

The need for right ventricular outflow tract reconstruction

The need for right ventricular outflow tract reconstruction Polytetrafluoroethylene Bicuspid Pulmonary Valve Implantation James A. Quintessenza, MD The need for right ventricular outflow tract reconstruction and pulmonary valve replacement is increasing for many

More information

The modified Konno procedure, or subaortic ventriculoplasty,

The modified Konno procedure, or subaortic ventriculoplasty, Modified Konno Procedure for Left Ventricular Outflow Tract Obstruction David P. Bichell, MD The modified Konno procedure, or subaortic ventriculoplasty, first described by Cooley and Garrett in1986, 1

More information

Adult Cardiac Surgery

Adult Cardiac Surgery Adult Cardiac Surgery Mahmoud ABU-ABEELEH Associate Professor Department of Surgery Division of Cardiothoracic Surgery School of Medicine University Of Jordan Adult Cardiac Surgery: Ischemic Heart Disease

More information

Outline. Congenital Heart Disease. Special Considerations for Special Populations: Congenital Heart Disease

Outline. Congenital Heart Disease. Special Considerations for Special Populations: Congenital Heart Disease Special Considerations for Special Populations: Congenital Heart Disease Valerie Bosco, FNP, EdD Alison Knauth Meadows, MD, PhD University of California San Francisco Adult Congenital Heart Program Outline

More information

The Double Switch Using Bidirectional Glenn and Hemi-Mustard. Frank Hanley

The Double Switch Using Bidirectional Glenn and Hemi-Mustard. Frank Hanley The Double Switch Using Bidirectional Glenn and Hemi-Mustard Frank Hanley No relationships to disclose CCTGA Interesting Points for Discussion What to do when. associated defects must be addressed surgically:

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information

SURGICAL TREATMENT AND OUTCOME OF CONGENITAL HEART DISEASE

SURGICAL TREATMENT AND OUTCOME OF CONGENITAL HEART DISEASE SURGICAL TREATMENT AND OUTCOME OF CONGENITAL HEART DISEASE Mr. W. Brawn Birmingham Children s Hospital. Aims of surgery The aim of surgery in congenital heart disease is to correct or palliate the heart

More information

Indications for the Brock operation in current

Indications for the Brock operation in current Thorax (1973), 28, 1. Indications for the Brock operation in current treatment of tetralogy of Fallot H. R. MATTHEWS and R. H. R. BELSEY Department of Thoracic Surgery, Frenchay Hospital, Bristol It is

More information

How to Assess and Treat Obstructive Lesions

How to Assess and Treat Obstructive Lesions How to Assess and Treat Obstructive Lesions Erwin Oechslin, MD, FESC, FRCPC, Director, Congenital Cardiac Centre for Adults Peter Munk Cardiac Centre University Health Network/Toronto General Hospital

More information

Repair of Complete Atrioventricular Septal Defects Single Patch Technique

Repair of Complete Atrioventricular Septal Defects Single Patch Technique Repair of Complete Atrioventricular Septal Defects Single Patch Technique Fred A. Crawford, Jr., MD The first repair of a complete atrioventricular septal defect was performed in 1954 by Lillehei using

More information

Aortic valve repair is a technique that is gaining popularity

Aortic valve repair is a technique that is gaining popularity Aortic Valve Repair in Children, Including Pericardial Patch Reconstruction Aditya K. Kaza, MD,* and John A. Hawkins, MD Aortic valve repair is a technique that is gaining popularity in children because

More information

C to challenge the medicallsurgical team. Although

C to challenge the medicallsurgical team. Although Critical Aortic Stenosis in the First Month of Life: Surgical Results in 26 Infants Tom R. Karl, MD, Shunji Sano, MD, William J. Brawn, FRCS, and Roger B. B. Mee, FRACS Victorian Pediatric Cardiac Surgical

More information

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical

More information

Coronary Artery from the Wrong Sinus of Valsalva: A Physiologic Repair Strategy

Coronary Artery from the Wrong Sinus of Valsalva: A Physiologic Repair Strategy Coronary Artery from the Wrong Sinus of Valsalva: A Physiologic Repair Strategy Tom R. Karl, MS, MD he most commonly reported coronary artery malformation leading to sudden death in children and young

More information

The application of autologous pulmonary artery in surgical correction of complicated aortic arch anomaly

The application of autologous pulmonary artery in surgical correction of complicated aortic arch anomaly Original Article The application of autologous pulmonary artery in surgical correction of complicated aortic arch anomaly Shusheng Wen, Jianzheng Cen, Jimei Chen, Gang Xu, Biaochuan He, Yun Teng, Jian

More information

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for

More information

Aortic valve repair is an accepted option for aortic valve

Aortic valve repair is an accepted option for aortic valve Complex Aortic Valve Disease in Children Christopher W. Baird, MD,* and Pedro J. del Nido, MD Aortic valve repair is an accepted option for aortic valve pathologic conditions in children and young adults.

More information

Disease of the aortic valve is frequently associated with

Disease of the aortic valve is frequently associated with Stentless Aortic Bioprosthesis for Disease of the Aortic Valve, Root and Ascending Aorta John R. Doty, MD, and Donald B. Doty, MD Disease of the aortic valve is frequently associated with morphologic abnormalities

More information

Tetralogy of Fallot (TOF) with absent pulmonary valve

Tetralogy of Fallot (TOF) with absent pulmonary valve Repair of Tetralogy of Fallot with Absent Pulmonary Valve Syndrome Karl F. Welke, MD, and Ross M. Ungerleider, MD, MBA Tetralogy of Fallot (TOF) with absent pulmonary valve syndrome (APVS) occurs in 5%

More information

Late Outcome of Survivors of Intervention for Neonatal Aortic Valve Stenosis

Late Outcome of Survivors of Intervention for Neonatal Aortic Valve Stenosis Late Outcome of Survivors of Intervention for Neonatal Aortic Valve Stenosis J. William Gaynor, MD, Catherine Bull, MD, Ian D. Sullivan, MD, Brenda E. Armstrong, MD, John E. Deanfield, FRCP, James F. N.

More information

CONTRIBUTION. Aortic valve replacement in young patients: long-term follow-up

CONTRIBUTION. Aortic valve replacement in young patients: long-term follow-up CONTRIBUTION Aortic valve replacement in young patients: long-term follow-up DOUGLAS S. MOODIE, MD; USAMA HANHAN, MD; RICHARD STERBA, MD; DANIEL J. MURPHY, Jr, MD; ELIOT R. ROSENKRANZ, MD; ANDREA M. KOVACS,

More information

Cardiac Catheterization Cases Primary Cardiac Diagnoses Facility 12 month period from to PRIMARY DIAGNOSES (one per patient)

Cardiac Catheterization Cases Primary Cardiac Diagnoses Facility 12 month period from to PRIMARY DIAGNOSES (one per patient) PRIMARY DIAGNOSES (one per patient) Septal Defects ASD (Atrial Septal Defect) PFO (Patent Foramen Ovale) ASD, Secundum ASD, Sinus venosus ASD, Coronary sinus ASD, Common atrium (single atrium) VSD (Ventricular

More information

Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency

Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency Ken-ichi ASANO, M.D., Masahiko WASHIO, M.D., and Shoji EGUCHI, M.D. SUMMARY (1) Surgical results of

More information

Inflow Occlusion for Semilunar Valve Stenosis

Inflow Occlusion for Semilunar Valve Stenosis Inflow Occlusion for Semilunar Valve Stenosis Robert M. Sade, M.D., Fred A. Crawford, M.D., and Arno R. Hohn, M.D ABSTRACT Twenty-nine patients have had valvotomy with inflow occlusion since 1975 at our

More information

Appendix A.1: Tier 1 Surgical Procedure Terms and Definitions

Appendix A.1: Tier 1 Surgical Procedure Terms and Definitions Appendix A.1: Tier 1 Surgical Procedure Terms and Definitions Tier 1 surgeries AV Canal Atrioventricular Septal Repair, Complete Repair of complete AV canal (AVSD) using one- or two-patch or other technique,

More information

Carpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience

Carpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://www.annalsthoracicsurgery.org/cme/ home. To take the CME activity related to this article, you must have either an STS member

More information

Although most patients with Ebstein s anomaly live

Although most patients with Ebstein s anomaly live Management of Neonatal Ebstein s Anomaly Christopher J. Knott-Craig, MD, FACS Although most patients with Ebstein s anomaly live through infancy, those who present clinically as neonates are a distinct

More information

42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim

42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim 42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of

More information

Reoperation for Left Ventricular Outflow Tract Obstruction After Repair of Atrioventricular Septal Defect

Reoperation for Left Ventricular Outflow Tract Obstruction After Repair of Atrioventricular Septal Defect Reoperation for Left Ventricular Outflow Tract Obstruction After Repair of Atrioventricular Septal Defect David M. Overman Division of Pediatric Cardiac Surgery The Children s Heart Clinic Chief, Division

More information

Surgical treatment of ventricular septal defect

Surgical treatment of ventricular septal defect Thorax (1965), 20, 278. VIKING OLOV BJORK From the Department of Thoracic Surgery, University Hospital, Uppsala, Sweden Since the first report of direct vision closure of ventricular septal defects in

More information

Pediatric Echocardiography Examination Content Outline

Pediatric Echocardiography Examination Content Outline Pediatric Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 Anatomy and Physiology Normal Anatomy and Physiology 10% 2 Abnormal Pathology and Pathophysiology

More information

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,

More information

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More? CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology

More information

Surgical Treatment for Double Outlet Right Ventricle. Masakazu Nakao Consultant, Paediatric Cardiothoracic Surgery

Surgical Treatment for Double Outlet Right Ventricle. Masakazu Nakao Consultant, Paediatric Cardiothoracic Surgery for Double Outlet Right Ventricle Masakazu Nakao Consultant, Paediatric Cardiothoracic Surgery 1 History Intraventricular tunnel (Kawashima) First repair of Taussig-Bing anomaly (Kirklin) Taussig-Bing

More information

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This

More information

Pulmonary Valve Replacement

Pulmonary Valve Replacement Pulmonary Valve Replacement with Fascia Lata J. C. R. Lincoln, F.R.C.S., M. Geens, M.D., M. Schottenfeld, M.D., and D. N. Ross, F.R.C.S. ABSTRACT The purpose of this paper is to describe a technique of

More information

The first report of the Society of Thoracic Surgeons

The first report of the Society of Thoracic Surgeons REPORT The Society of Thoracic Surgeons National Congenital Heart Surgery Database Report: Analysis of the First Harvest (1994 1997) Constantine Mavroudis, MD, Melanie Gevitz, BA, W. Steves Ring, MD, Charles

More information

TSDA ACGME Milestones

TSDA ACGME Milestones TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short

More information

The Edge-to-Edge Technique f For Barlow's Disease

The Edge-to-Edge Technique f For Barlow's Disease The Edge-to-Edge Technique f For Barlow's Disease Ottavio Alfieri, Michele De Bonis, Elisabetta Lapenna, Francesco Maisano, Lucia Torracca, Giovanni La Canna. Department of Cardiac Surgery, San Raffaele

More information

S ical Spectrum of Aortic Stenosis in

S ical Spectrum of Aortic Stenosis in S ical Spectrum of Aortic Stenosis in adren: A Thirty-Year Experience with 257 Children John W. Brown, M.D., Larry S. Stevens, M.D., Scott Holly, B.S., Robert Robison, M.D., Mark Rodefeld, B.S., Tom Grayson,

More information

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands Minimal Invasive Mitral Valve Surgery After Previous Sternotomy Without Aortic Clamping: Short- and Long Term Results of a Single Surgeon Single Institution Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart

More information

Clinical material and methods. Copyright by ICR Publishers 2003

Clinical material and methods. Copyright by ICR Publishers 2003 Fourteen Years Experience with the CarboMedics Valve in Young Adults with Aortic Valve Disease Jan Aagaard 1, Jens Tingleff 2, Per V. Andersen 1, Christel N. Hansen 2 1 Department of Cardio-Thoracic and

More information

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material

More information

Adult Congenital Heart Disease: What All Echocardiographers Should Know Sharon L. Roble, MD, FACC Echo Hawaii 2016

Adult Congenital Heart Disease: What All Echocardiographers Should Know Sharon L. Roble, MD, FACC Echo Hawaii 2016 1 Adult Congenital Heart Disease: What All Echocardiographers Should Know Sharon L. Roble, MD, FACC Echo Hawaii 2016 DISCLOSURES I have no disclosures relevant to today s talk 2 Why should all echocardiographers

More information

The vast majority of patients, especially children, who

The vast majority of patients, especially children, who Technique of Mechanical Pulmonary Valve Replacement John M. Stulak, MD, and Joseph A. Dearani, MD The vast majority of patients, especially children, who require pulmonary valve replacement (PVR), obtain

More information

Obstructed total anomalous pulmonary venous connection

Obstructed total anomalous pulmonary venous connection Total Anomalous Pulmonary Venous Connection Richard A. Jonas, MD Children s National Medical Center, Department of Cardiovascular Surgery, Washington, DC. Address reprint requests to Richard A. Jonas,

More information

CLINICAL COMMUNIQUE 16 YEAR RESULTS

CLINICAL COMMUNIQUE 16 YEAR RESULTS CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced

More information

Conversion of Atriopulmonary to Cavopulmonary Anastomosis in Management of Late Arrhythmias and Atrial Thrombosis

Conversion of Atriopulmonary to Cavopulmonary Anastomosis in Management of Late Arrhythmias and Atrial Thrombosis Conversion of Atriopulmonary to Cavopulmonary Anastomosis in Management of Late Arrhythmias and Atrial Thrombosis Jane M. Kao, MD, Juan c. Alejos, MD, Peter W. Grant, MD, Roberta G. Williams, MD, Kevin

More information

For Personal Use. Copyright HMP 2013

For Personal Use. Copyright HMP 2013 12-00415 Case Report J INVASIVE CARDIOL 2013;25(4):E69-E71 A Concert in the Heart. Bilateral Melody Valve Implantation in the Branch Pulmonary Arteries Nicola Maschietto, MD, PhD and Ornella Milanesi,

More information

(Ann Thorac Surg 2008;85:845 53)

(Ann Thorac Surg 2008;85:845 53) I Made Adi Parmana The utility of intraoperative TEE has become increasingly more evident as anesthesiologists, cardiologists, and surgeons continue to appreciate its potential application as an invaluable

More information

Quality Outcomes Mitral Valve Repair

Quality Outcomes Mitral Valve Repair Quality Outcomes Mitral Valve Repair Moving Beyond Reoperation Rakesh M. Suri, D.Phil. Professor of Surgery 2015 MFMER 3431548-1 Disclosure Mayo Clinic Division of Cardiovascular Surgery Research funding

More information

Adult Echocardiography Examination Content Outline

Adult Echocardiography Examination Content Outline Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,

More information

Supplemental Table 1. ICD-9 Codes for Diagnoses and Procedures

Supplemental Table 1. ICD-9 Codes for Diagnoses and Procedures Supplemental Table 1. ICD-9 Codes for Diagnoses and Procedures ICD-9 Code Description Heart Failure 402.01 Malignant hypertensive heart disease with heart failure 402.11 Benign hypertensive heart disease

More information

Autologous Pulmonary Valve Replacement of the Diseased Aortic Valve

Autologous Pulmonary Valve Replacement of the Diseased Aortic Valve Autologous Pulmonary Valve Replacement of the Diseased Aortic Valve By L. GONZALEZ-LAvIN, M.D., M. GEENS. M.D., J. SOMERVILLE, M.D., M.R.C.P., ANm D. N. Ross, M.B., CH.B., F.R.C.S. SUMMARY Living tissue

More information

Surgical Results in Patients With Double Outlet Right Ventricle: A 20-Year Experience

Surgical Results in Patients With Double Outlet Right Ventricle: A 20-Year Experience Surgical Results in Patients With Double Outlet Right Ventricle: A 20-Year Experience John W. Brown, MD, Mark Ruzmetov, MD, Yuji Okada, MD, Palaniswamy Vijay, PhD, MPH, and Mark W. Turrentine, MD Section

More information

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts

More information

Atrioventricular valve repair: The limits of operability

Atrioventricular valve repair: The limits of operability Atrioventricular valve repair: The limits of operability Francis Fynn-Thompson, MD Co-Director, Center for Airway Disorders Surgical Director, Pediatric Mechanical Support Program Surgical Director, Heart

More information

The evolution of the Fontan procedure for single ventricle

The evolution of the Fontan procedure for single ventricle Hemi-Fontan Procedure Thomas L. Spray, MD The evolution of the Fontan procedure for single ventricle cardiac malformations has included the development of several surgical modifications that appear to

More information

ACD. Tirone E. David, MD, Christopher M. Feindel, MD, Susan Armstrong, MSc, and Manjula Maganti, MSc

ACD. Tirone E. David, MD, Christopher M. Feindel, MD, Susan Armstrong, MSc, and Manjula Maganti, MSc Replacement of the ascending aorta with reduction of the diameter of the sinotubular junction to treat aortic insufficiency in patients with ascending aortic aneurysm Tirone E. David, MD, Christopher M.

More information

Replacement of the mitral valve in the presence of

Replacement of the mitral valve in the presence of Mitral Valve Replacement in Patients with Mitral Annulus Abscess Christopher M. Feindel Replacement of the mitral valve in the presence of an abscess of the mitral annulus presents a major challenge to

More information

Surgical Procedures and Complications

Surgical Procedures and Complications Radiological Society of North America, RSNA 2013 Refresher Course Program: Vascular Track Surgical Procedures and Complications Learning objectives Outline RC 112 : Key Concepts: Surgical Procedures and

More information

Surgical Repairs for LVOT Obstructive Lesions. John J. Lamberti MD

Surgical Repairs for LVOT Obstructive Lesions. John J. Lamberti MD Surgical Repairs for LVOT Obstructive Lesions John J. Lamberti MD Surgical Repairs for LVOT Obstructive Lesions Presented by John J. Lamberti MD Faculty Disclosure Statement: I do not have any relevant

More information

The Role Of Decellularized Valve Prostheses In The Young Patient

The Role Of Decellularized Valve Prostheses In The Young Patient The Role Of Decellularized Valve Prostheses In The Young Patient Francisco Diniz Affonso da Costa Human Tissue Bank PUCPR - Brazil Disclosures Ownership and patent license of the SDS decellularization

More information

Clinical outcomes of aortic root replacement after previous aortic root replacement

Clinical outcomes of aortic root replacement after previous aortic root replacement Clinical outcomes of aortic root replacement after previous aortic root replacement Luis Garrido-Olivares, MD, MSc, Manjula Maganti, MSc, Susan Armstrong, MSc, and Tirone E. David, MD Objective: The study

More information

Surgical Management of TOF in Adults. Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital

Surgical Management of TOF in Adults. Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital Surgical Management of TOF in Adults Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital Tetralogy of Fallot (TOF) in Adults Most common cyanotic congenital heart

More information

The arterial switch operation has been the accepted procedure

The arterial switch operation has been the accepted procedure The Arterial Switch Procedure: Closed Coronary Artery Transfer Edward L. Bove, MD The arterial switch operation has been the accepted procedure for the repair of transposition of the great arteries (TGA)

More information

The management of patients born with multiple left heart

The management of patients born with multiple left heart Predictors of Outcome of Biventricular Repair in Infants With Multiple Left Heart Obstructive Lesions Marcy L. Schwartz, MD; Kimberlee Gauvreau, ScD; Tal Geva, MD Background Decisions regarding surgical

More information

Idiopathic Hypertrophic Subaortic Stenosis and Mitral Stenosis

Idiopathic Hypertrophic Subaortic Stenosis and Mitral Stenosis CASE REPORTS Idiopathic Hypertrophic Subaortic Stenosis and Mitral Stenosis Martin J. Nathan, M.D., Roman W. DeSanctis, M.D., Mortimer J. Buckley, M.D., Charles A. Sanders, M.D., and W. Gerald Austen,

More information

Since first successfully performed by Jatene et al, the

Since first successfully performed by Jatene et al, the Long-Term Predictors of Aortic Root Dilation and Aortic Regurgitation After Arterial Switch Operation Marcy L. Schwartz, MD; Kimberlee Gauvreau, ScD; Pedro del Nido, MD; John E. Mayer, MD; Steven D. Colan,

More information

Adult Congenital Heart Disease: A Growing Problem. Dr. Gary Webb Cincinnati Children s Hospital Heart Institute

Adult Congenital Heart Disease: A Growing Problem. Dr. Gary Webb Cincinnati Children s Hospital Heart Institute Adult Congenital Heart Disease: A Growing Problem Dr. Gary Webb Cincinnati Children s Hospital Heart Institute ACHD Resources in Ohio ACHAHEART.ORG Situations When We Might Help When you don t know a

More information

The Management of HOCM: What are the Surgical Options

The Management of HOCM: What are the Surgical Options The Management of HOCM: What are the Surgical Options Konstadinos A Plestis, MD System Chief of Cardiac Thoracic and Vascular Surgery Main Line Health Care System Professor Sidney Kimmel Medical College

More information

The clinical problem of atrioventricular valve regurgitation

The clinical problem of atrioventricular valve regurgitation Mitral Regurgitation in Congenital Heart Defects: Surgical Techniques for Reconstruction Richard G. Ohye Mitral valve regurgitation (MR) is an important source of morbidity and mortality worldwide. While

More information

Mechanical Bleeding Complications During Heart Surgery

Mechanical Bleeding Complications During Heart Surgery Mechanical Bleeding Complications During Heart Surgery Arthur C. Beall, Jr., M.D., Kenneth L. Mattox, M.D., Mary Martin, R.N., C.C.P., Bonnie Cromack, C.C.P., and Gary Cornelius, C.C.P. * Potential for

More information